ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Retransplantation"

  • 2021 American Transplant Congress

    Evolving Trends in Risk Profiles and Outcomes in Older Adults Undergoing Kidney Re-Transplantation

    S. Sandal1, J. Ahn2, M. Cantarovich1, N. Chu2, D. Segev2, M. McAdams DeMarco2

    1McGill University, Montreal, QC, Canada, 2Johns Hopkins University, Baltimore, MD

    *Purpose: The half-life of a kidney transplant (KT) is 8-12 years, and a significant proportion of patients end up with graft loss at age ≥65…
  • 2021 American Transplant Congress

    The Predictive Factors of Survival in Re-listed Patients Who Received Initial Liver Transplants Using Donation After Circulatory Death Grafts

    Y. Fouda, A. Moro, J. Mcvey, D. Firl, M. Fujiki, D. Teresa, F. Aucejo, C. Quintini, C. H. Kwon, K. Hashimoto, B. Eghtesad, K. Narayanan Menon, C. Miller, K. Sasaki

    Cleveland Clinic, Cleveland, OH

    *Purpose: The inherent risk of livers from donors after circulatory death (DCD) is well known such as primary non-function (PNF) and increased rates of biliary…
  • 2021 American Transplant Congress

    Predictive Index for Liver Retransplantation

    C. Christmann, G. Handing, M. McDonald, A. Anand, S. Keeling, N. T. Galván, R. Cotton, C. O'Mahony, J. Goss, A. Rana

    Baylor College of Medicine, Houston, TX

    *Purpose: Given the increase in demand for donor livers, it has become more critical than ever to predict mortality in order to identify the best…
  • 2021 American Transplant Congress

    Re-Transplantation of Mouse Kidney Grafts to Study Local Immune Responses

    D. Zhao, M. Oberbarnscheidt, F. Lakkis, K. Khodor

    Starzl Transplantation Institution, Pittsburgh, PA

    *Purpose: Mouse kidney transplantation has been widely used to study the immune response to allogeneic grafts. This response includes a circulating systemic compartment and a…
  • 2021 American Transplant Congress

    Comparison of Donor-derived Cell Free Dna Between Recipients with First Solitary Allograft and Regrafts

    S. Paluri1, S. Muthusamy1, M. Shinbashi1, G. Gupta1, B. Dale2, Z. Kashi3, P. Halloran4, D. Kumar1

    1Virginia Commonwealth University, Richmond, VA, 2CareDx, Brisbane, CA, 3Kashi Clinical Laboratories, Portland, OR, 4ATAGC, Edmonton, AB, Canada

    *Purpose: Donor derived-cell free DNA (dd-cfDNA) is a biomarker of immunological injury. Multiple studies have validated its utility in recipients of first solitary kidney transplants…
  • 2021 American Transplant Congress

    Immunosuppression Impacts Panel Reactive Antibody Status in Second Solid Organ Transplant Recipients – A Single Center Experience

    J. Patel1, S. Ali2, M. L. Sanders1, C. P. Thomas1, D. Axelrod1, M. Bilal3, E. H. Field3, S. Kuppachi1

    1University of Iowa Hospitals & Clinics, Iowa city, IA, 2Louis A. Johnson VA Medical Center, Clarksburg, WV, 3Iowa City VA Health Care System, Iowa city, IA

    *Purpose: Patients who require a second solid organ transplantation are significantly disadvantaged due to the event of sensitization due to the first transplant. We hypothesized…
  • 2021 American Transplant Congress

    Continuation of Immunosuppression After the First Renal Allograft Failure Impacts Panel Reactive Antibody Status During Subsequent Renal Transplantation

    J. Patel1, S. Ali2, M. L. Sanders3, C. P. Thomas3, D. Axelrod3, M. Bilal4, E. H. Field4, S. Kuppachi3

    1University of Iowa Hospitals & Clinics, Iowa CIty, IA, 2Louis A. Johnson VA Medical Center, Clarksburg, WV, 3University of Iowa Hospitals & Clinics, Iowa City, IA, 4Iowa City VA Health Care System, Iowa City, IA

    *Purpose: The standard of care following renal allograft failure is to discontinue immunosuppression (IS) to limit risks from further IS. We hypothesized that continuation of…
  • 2021 American Transplant Congress

    Donor-Derived Cell-Free DNA Performance Characteristics are Similar for Repeat and Primary Kidney Transplant Recipients

    V. R. Peddi1, S. Akkina2, S. C. Jordan3, W. Tian4, Y. Qazi5

    1California Pacific Medical Center, San Francisco, CA, 2Loyola University Medical Center, Maywood, IL, 3Cedars-Sinai Medical Center, Los Angeles, CA, 4CareDx, Brisbane, CA, 5University of Southern California, Los Angeles, CA

    *Purpose: Repeat kidney transplants (RKT) represent 12.4% of kidney transplants (KT) (10.9% of all living donor and 13.6% of all deceased donor). Most RKT are…
  • 2021 American Transplant Congress

    Preemptive Second Kidney Transplant Outcomes by Induction Type in the United States

    S. Riad1, G. Larrieux2, S. Jackson3, R. Kandaswamy2

    1Medicine, University of Minnesota, Minneapolis, MN, 2Surgery, University of Minnesota, Minneapolis, MN, 3Complex Care Analytics, M-Health Fairview, Minneapolis, MN

    *Purpose: Failed kidney allograft is the fourth leading indication for kidney transplantation. A significant portion of second kidney transplant recipients undergo preemptive transplantation while on…
  • 2020 American Transplant Congress

    Differences in Immunosuppressive Therapy among Liver Retransplantation Recipients in a National Cohort

    A. K. Mezochow, P. L. Abt, T. Bittermann

    Hospital of the University of Pennsylvania, Philadelphia, PA

    *Purpose: There is no unified consensus as to the preferred immunosuppression (IS) strategy following liver retransplantation (reLT). This study explored: (i) factors associated with induction…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 11
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences